In conclusion, the obtained gene expression profile of CD79B-mutated DLBCLs improves the characterization of this lymphoma subpopulation and contributes to a better understanding of the complex molecular heterogeneity of DLBCL. The gene discussed is CD79B; the disease is lymphoma.